-
1
-
-
1542327563
-
Drug-induced liver injury associated with the use of non nucleoside reverse-transcriptase inhibitors
-
Dieterich DT, Robinson PA, Love J, Stern JO. Drug-induced liver injury associated with the use of non nucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004;38 (Suppl. 2):S80-S89.
-
(2004)
Clin Infect Dis
, vol.38
, Issue.SUPPL. 2
-
-
Dieterich, D.T.1
Robinson, P.A.2
Love, J.3
Stern, J.O.4
-
2
-
-
23044453130
-
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy
-
Haugaard SB, Andersen O, Pedersen SB, Dela F, Richelsen B, Nielsen JO, et al. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. J Med Virol 2005;77:29-38.
-
(2005)
J Med Virol
, vol.77
, pp. 29-38
-
-
Haugaard, S.B.1
Andersen, O.2
Pedersen, S.B.3
Dela, F.4
Richelsen, B.5
Nielsen, J.O.6
-
3
-
-
0037045058
-
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors
-
Walker UA, Setzer B, Venhoff N. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 2002; 16: 2165-2173.
-
(2002)
AIDS
, vol.16
, pp. 2165-2173
-
-
Walker, U.A.1
Setzer, B.2
Venhoff, N.3
-
4
-
-
1642540100
-
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals
-
Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 2004;35:120-125.
-
(2004)
J Acquir Immune Defic Syndr
, vol.35
, pp. 120-125
-
-
Patel, S.M.1
Johnson, S.2
Belknap, S.M.3
Chan, J.4
Sha, B.E.5
Bennett, C.6
-
5
-
-
0034614136
-
Adverse effects associated with use of nevirapine in HIV exposure prophylaxis for 2 health care workers
-
Sha BE, Proia LA, Kessler HA. Adverse effects associated with use of nevirapine in HIV exposure prophylaxis for 2 health care workers. JAMA 2000;284:2723.
-
(2000)
JAMA
, vol.284
, pp. 2723
-
-
Sha, B.E.1
Proia, L.A.2
Kessler, H.A.3
-
6
-
-
0035208379
-
Nevirapine-induced hepatitis: A case series and review of the literature
-
Piliero PJ, Purdy B. Nevirapine-induced hepatitis: a case series and review of the literature. AIDS Read 2001;11: 379-382.
-
(2001)
AIDS Read
, vol.11
, pp. 379-382
-
-
Piliero, P.J.1
Purdy, B.2
-
7
-
-
14944346065
-
Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine
-
De Maat MM, Beijnen JH, Schellens JH, Mulder JW. Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine. J Infect 2005:50:262-264.
-
(2005)
J Infect
, vol.50
, pp. 262-264
-
-
De Maat, M.M.1
Beijnen, J.H.2
Schellens, J.H.3
Mulder, J.W.4
-
8
-
-
0036713965
-
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: A case report
-
Jain AK, Venkataramanan R, Fridell JA, Gadomski M, Shaw LM, Ragni M, et al. Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report. Liver Transpl 2002;8:838-840.
-
(2002)
Liver Transpl
, vol.8
, pp. 838-840
-
-
Jain, A.K.1
Venkataramanan, R.2
Fridell, J.A.3
Gadomski, M.4
Shaw, L.M.5
Ragni, M.6
-
9
-
-
0141681334
-
A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients
-
Stern JO, Robinso, PA, Love J, Lanes S, Imperiale MS, Mayers DL. A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients. J Acquir Immune Defic Syndr 2003;34:S21-S33.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
-
-
Stern, J.O.1
Robinso, P.A.2
Love, J.3
Lanes, S.4
Imperiale, M.S.5
Mayers, D.L.6
-
10
-
-
12144260460
-
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1 *0101 and abrogated by low CD4 T-cell counts
-
Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, et al. Predisposition to nevirapine hypersensitivity associated with HLA-DRB1 *0101 and abrogated by low CD4 T-cell counts. AIDS 2005;19:97-99.
-
(2005)
AIDS
, vol.19
, pp. 97-99
-
-
Martin, A.M.1
Nolan, D.2
James, I.3
Cameron, P.4
Keller, J.5
Moore, C.6
-
11
-
-
30144435244
-
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
-
Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 2006;44:S132-S139.
-
(2006)
J Hepatol
, vol.44
-
-
Nunez, M.1
|